A recent study highlighted the importance of radiotherapy in improving the success rates of bone marrow transplants for patients diagnosed with leukemia. This type of cancer, which affects blood cells, leads to the production of dysfunctional cells that crowd out healthy ones, making effective treatment critical. The Brazilian National Cancer Institute (INCA) reports an estimated 12,000 new leukemia cases per year between 2026 and 2028, underlining the urgency for effective treatment options.

Leukemia can be classified into two forms based on its progression speed: acute and chronic. Acute leukemia develops rapidly and requires immediate intervention, whereas chronic leukemia progresses more gradually. The effectiveness of treatment depends on the subtype of leukemia, whether lymphoid or myeloid. Radiotherapy serves as an adjunct to transplant procedures, enhancing the likelihood of a successful recovery by clearing diseased cells and establishing a healthier environment for transplantation.

These findings represent a significant advancement in the treatment of leukemia, particularly in Brazil, where the incidence is notably high. By integrating radiotherapy into treatment protocols before transplants, healthcare professionals aim to improve patient outcomes, reduce the likelihood of relapse, and ultimately enhance survival rates. The study advocates for increased adoption of this method in clinical practice, which could transform the landscape of leukemia treatment in the region.